Eric Nuermberger

PROFESSOR

19992019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Tuberculosis Medicine & Life Sciences
rifapentine Medicine & Life Sciences
Pyrazinamide Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Linezolid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection

Kaushik, A., Ammerman, N., Tyagi, S., Saini, V., Vervoort, I., Lachau-Durand, S., Nuermberger, E. & Andries, K., Apr 1 2019, In : Antimicrobial agents and chemotherapy. e00007-19.

Research output: Contribution to journalArticle

Open Access
bedaquiline
Latent Tuberculosis
Injections
rifapentine
Lung

High-dose rifamycins enable shorter oral treatment in a murine model of mycobacterium ulcerans disease

Omansen, T. F., Almeida, D., Converse, P. J., Li, S. Y., Lee, J., Stienstra, Y., van der Werf, T., Grosset, J. H. & Nuermberger, E., Feb 1 2019, In : Antimicrobial Agents and Chemotherapy. 63, 2, e01478-18.

Research output: Contribution to journalArticle

rifapentine
Rifamycins
Mycobacterium ulcerans
Rifampin
Buruli Ulcer
Lactams
Mycobacterium
meropenem
Cefuroxime
Carbapenems

One month of rifapentine plus isoniazid to prevent HIV-related Tuberculosis

BRIEF TB/A5279 Study Team, Mar 14 2019, In : New England Journal of Medicine. 380, 11, p. 1001-1011 11 p.

Research output: Contribution to journalArticle

rifapentine
Isoniazid
Tuberculosis
HIV
Confidence Intervals

Oxazolidinones can replace clarithromycin in combination with rifampin in a mouse model of Buruli ulcer

Almeida, D. V., Omansen, T. F., Li, S. Y., Lee, J., Grosset, J. H., Converse, P. J. & Nuermberger, E., Mar 1 2019, In : Antimicrobial agents and chemotherapy. e02171-18.

Research output: Contribution to journalArticle

Buruli Ulcer
Linezolid
Oxazolidinones
Clarithromycin
Rifampin